Register for the ISN Webinar on Thrombotic Microangiopathies
The ISN and the Mario Negri Institute for Pharmacological Research will hold the first of two webinars on September 17, 2021, at 2 p.m. CEST on:
“New Insights into Clinical Management of Complement-mediated Thrombotic Microangiopathies”
The webinar will address:
- Identifying patients with complement-mediated TMA
- The impact of genetic and biochemical characterization
- Treatment recommendations
- Clinical perspectives of emerging complement inhibitors
The webinar supports the ISN Frontiers Meeting “Complement-related Kidney Diseases: Classification, Genetics, and Treatment,” which will take place in Bergamo from June 23-25, 2022.
The ISN Frontiers meetings offer cutting-edge science and state-of-the-art lectures in specialist topics to a global audience. The Bergamo edition will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS) and C3 Glomerulopathies /Membranoproliferative Glomerulonephritis (C3G/MPGN), both very rare and severe conditions.
